Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Hartmann

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Glia|February 2, 2008
Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injuryYasmine Nadler, Alexander Alexandrovich, Nikolaos Grigoriadis, et al.
Cellular and Molecular Life Sciences : CMLS|January 2, 2019
Transcriptional repression of the ectodomain sheddase ADAM10 by TBX2 and potential implication for Alzheimer's diseaseSven Reinhardt, Florian Schuck, Nicolai Stoye, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2013
Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's diseaseSven Reinhardt, Florian Schuck, Sven Grösgen, et al.
Plos One|August 8, 2019
A novel and highly efficient purification procedure for native human dipeptidyl peptidase 3 from human blood cell lysatePaul Kaufmann, Matthias Muenzner, Mandy Kästorf, et al.
The Lancet. Neurology|November 4, 2017
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.
Neurobiology of Aging|May 16, 2013
Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in miceKan Xie, Yang Liu, Wenlin Hao, et al.
Current Alzheimer Research|June 24, 2016
Rescue of Hypovitaminosis A Induces Non-Amyloidogenic Amyloid Precursor Protein (APP) ProcessingSven Reinhardt, Marcus O W Grimm, Christoph Stahlmann, et al.
Neuroscience Letters|May 2, 2002
Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controlsPeter Schönknecht, Dieter Lütjohann, Johannes Pantel, et al.
Frontiers in Aging Neuroscience|January 7, 2014
Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's DiseaseMarcus O W Grimm, Janine Mett, Christoph P Stahlmann, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2024
Identification and structural elucidation of an oxidation product generated during stability studies of Cabergoline drug productTilman Lechel, Ruben Silva Otero, Andreas Springer, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Glia|February 2, 2008
Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injuryYasmine Nadler, Alexander Alexandrovich, Nikolaos Grigoriadis, et al.
Cellular and Molecular Life Sciences : CMLS|January 2, 2019
Transcriptional repression of the ectodomain sheddase ADAM10 by TBX2 and potential implication for Alzheimer's diseaseSven Reinhardt, Florian Schuck, Nicolai Stoye, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2013
Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's diseaseSven Reinhardt, Florian Schuck, Sven Grösgen, et al.
Plos One|August 8, 2019
A novel and highly efficient purification procedure for native human dipeptidyl peptidase 3 from human blood cell lysatePaul Kaufmann, Matthias Muenzner, Mandy Kästorf, et al.
The Lancet. Neurology|November 4, 2017
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.
Neurobiology of Aging|May 16, 2013
Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in miceKan Xie, Yang Liu, Wenlin Hao, et al.
Current Alzheimer Research|June 24, 2016
Rescue of Hypovitaminosis A Induces Non-Amyloidogenic Amyloid Precursor Protein (APP) ProcessingSven Reinhardt, Marcus O W Grimm, Christoph Stahlmann, et al.
Neuroscience Letters|May 2, 2002
Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controlsPeter Schönknecht, Dieter Lütjohann, Johannes Pantel, et al.
Frontiers in Aging Neuroscience|January 7, 2014
Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's DiseaseMarcus O W Grimm, Janine Mett, Christoph P Stahlmann, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2024
Identification and structural elucidation of an oxidation product generated during stability studies of Cabergoline drug productTilman Lechel, Ruben Silva Otero, Andreas Springer, et al.
Pageof 13